2027 ICD-10-CM Diagnosis Code J91.0Malignant pleural effusion

ICD-10-CM Codes›J00–J99›J90-J94›J91

ICD-10-CM J91.0
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

J91.0 is a billable ICD-10-CM diagnosis code for malignant pleural effusion. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 180 through 182. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 27 closely related codes. The code is a manifestation code that cannot be reported as the principal diagnosis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Conditions due to neoplasm or the treatment of neoplasm; and Pleurisy, pleural effusion and pulmonary collapse.

For Medicare Advantage risk adjustment, J91.0 maps to CMS-HCC Category 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) under the V28 model, adding a risk factor of about 4.209 for a community, non-dual, aged beneficiary in payment year 2027.

Code Identity

ICD-10-CM Code
J91.0
Billable Status
Yes — Valid for Submission
Code Describes
Malignant pleural effusion
Short Description
Malignant pleural effusion
Same as the full description in the CMS dataset.
Parent Code
Pleural effusion in conditions classified elsewhere

Code Classification

ChapterJ00–J99Diseases of the respiratory system
SectionJ90-J94Other diseases of the pleura
CategoryJ91Pleural effusion in conditions classified elsewhere
This CodeJ91.0Malignant pleural effusion

Code EditsBilling

Medicare Code Editor checks that affect claim validity for J91.0.

Manifestation codes describe the manifestation of an underlying disease, not the disease itself, and therefore should not be used as a principal diagnosis.

Medicare Risk Adjustment (HCC)Billing

J91.0 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.

CMS-HCC V28 Category (Payment Model)
HCC 17— Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic
Payment HCC · PY 2027 one of 78 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+4.209
community, non-dual, aged · ranges 1.952–4.235 across segments
Hierarchy
Supersedes HCC 18, HCC 19, HCC 20, HCC 21, HCC 22, and HCC 23
less severe related categories are not paid alongside HCC 17
Prior Model (CMS-HCC V24)
Not mapped under V24
this diagnosis newly risk-adjusts under the V28 model
Part D (RxHCC)
Not mapped
J91.0 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to J91.0: its own notes plus those printed at J91 and Chapter 10. A note printed at a category, block or chapter applies to every code under it.

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From J91 Pleural effusion in conditions classified elsewhere applies to 2 codes
  • pleural effusion in heart failure (I50.-)
  • pleural effusion in systemic lupus erythematosus (M32.13)
From Chapter 10 (J00-J99) Diseases of the respiratory system applies to 366 codes
  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • smoke inhalation (T59.81-)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Code First

The underlying condition named in the note is sequenced before this code.

Use Additional Code

Add a second code, after this one, to fully describe the condition.

From Chapter 10 (J00-J99) Diseases of the respiratory system applies to 366 codes
  • code, where applicable, to identify:
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)

Notes

General instructions on how these codes are used.

From Chapter 10 (J00-J99) Diseases of the respiratory system applies to 366 codes
  • When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name J91.0, its category, or a range that includes it.

Excludes1 1

These codes carry an Excludes1 note naming J91.0: they are not reported together with it, unless the two conditions are unrelated.

  • J90 Pleural effusion, not elsewhere classified
    malignant pleural effusion (J91.0))

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO074
Conditions due to neoplasm or the treatment of neoplasm
Default principal diagnosis: inpatient No · outpatient No
CCSR RSP011
Pleurisy, pleural effusion and pulmonary collapse
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Pleural Effusion, Malignant

    presence of fluid in the pleural cavity as a complication of malignant disease. malignant pleural effusions often contain actual malignant cells.

Patient EducationClinical

Pleural Disorders

Your pleura is a large, thin sheet of tissue that wraps around the outside of your lungs and lines the inside of your chest cavity. Between the layers of the pleura is a very thin space. Normally it's filled with a small amount of fluid.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert J91.0 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
511.81 Malignant pleural effusn
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About J91.0Overview

What is the ICD-10 code for malignant pleural effusion?

The ICD-10-CM code for malignant pleural effusion is J91.0 (sometimes written as J910). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is J91.0 (Pleural effusion in conditions classified elsewhere) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant pleural effusion on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does J91.0 group to?

On inpatient claims, malignant pleural effusion maps to MS-DRG 181, 180, 182, with relative weights from 0.7436 to 1.7800 depending on complications. Higher weights mean higher Medicare reimbursement.

Is J91.0 a CC or MCC?

CMS lists J91.0 as a CC (complication or comorbidity) for FY 2027. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 27 closely related codes in its exclusion list.

Can J91.0 be a principal diagnosis?

No. This is a manifestation code: malignant pleural effusion describes the manifestation of an underlying disease rather than the disease itself, so the underlying condition is sequenced first.

What HCC is J91.0?

J91.0 (malignant pleural effusion) maps to CMS-HCC Category 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic), commonly written as HCC 17, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It does not map to any RxHCC in the Part D prescription drug model.

Does J91.0 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, J91.0 adds a risk adjustment factor of about 4.209 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 1.952 to 4.235 depending on the payment segment). HCC 17 sits at the top of its hierarchy, so no other condition category supersedes it. See the full factor table on the HCC 17 category page.